Precision BioSciences, Inc.
DTIL
$4.71
$0.020.43%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.76% | -98.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.76% | -98.85% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 10.76% | -98.85% | |||
| SG&A Expenses | -14.37% | 2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.63% | -15.15% | |||
| Operating Income | -16.78% | -188.11% | |||
| Income Before Tax | -8.04% | -150.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.04% | -150.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.04% | -150.15% | |||
| EBIT | -16.78% | -188.11% | |||
| EBITDA | -18.64% | -181.46% | |||
| EPS Basic | 1.58% | -147.95% | |||
| Normalized Basic EPS | 9.40% | -149.33% | |||
| EPS Diluted | 1.53% | -148.27% | |||
| Normalized Diluted EPS | 9.40% | -149.65% | |||
| Average Basic Shares Outstanding | 9.77% | 4.60% | |||
| Average Diluted Shares Outstanding | 9.77% | 3.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
